drugset / Trial / NCT02976441

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

NCT02976441

NaSingle-groupOpen-labelTreatment

Summary

The investigators hypothesize that this study will show that sufficient lymphocyte stem cell can be harvested prior chemoradiation and be reinfused back after treatment, and at least 5 of the 10 patients (50%) will achieve an absolute increase of lymphocyte counts of 300 cells/mm\^3 four weeks after stem cell reinfusion in high grade glioma patients.

Timeline

Start
2017-01
Primary completion
2018-02
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule Oral